Ready To Welcome To...
Health Care: Health Services
Genomic Health Inc. (GHDX: NASDAQ)
$37.00 0.00 | 0.00%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 8.25M | 7.85M | 4.29M | -9.41M |
| Operating Gains/Losses | 12.00K | 158.00K | -45.00K | -44.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -1.18M | -6.77M | -3.18M | -2.32M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -2.14M | 3.06M | 2.66M | -594.00K |
| (Decrease) Increase In Other Current Liabilities | 1.92M | 972.00K | 2.10M | 1.49M |
| (Increase) Decrease In Other Working Capital | -50.00K | -1.20M | 583.00K | 0.00 |
| Other Non-Cash Items | 15.28M | 11.74M | 10.36M | 10.24M |
| Net Cash From Continuing Operations | 25.96M | 22.47M | 21.58M | 4.83M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 25.96M | 22.47M | 21.58M | 4.83M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 87.00M | 57.22M |
| Purchases of Property, Plant & Equipment | -9.85M | -6.18M | -4.44M | -3.74M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -84.30M | -60.32M |
| Other Cash from Investing Activities | 0.00 | -133.99M | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -28.22M | -30.47M | -2.24M | -6.84M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 17.49M | 9.69M | 2.98M | 1.74M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | -225.00K | -1.81M |
| Repurchase of Capital Stock | -30.10M | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | -12.60M | 9.69M | 2.76M | -78.00K |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -14.86M | 1.69M | 22.10M | -2.09M |
Portfolios with GHDX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
Latest GHDX Headlines from TheStreet
- 4 Stocks Rising on Unusual Volume 03.29.13 | 07:03 am
- Top Insider Trades: GHDX, CLMS, IRM, FAST 02.22.13 | 09:02 am
- 5 Stocks With Big Insider Buying 02.13.13 | 12:02 pm
- 5 Stocks Poised for Breakouts 01.04.13 | 01:01 pm
- Short Sellers Are More Bullish About These Hedge Fund Favorites 12.20.12 | 04:12 pm
- 11 Stocks With Significant Institutional And Insider Buying 12.18.12 | 06:12 pm
- 10 Stocks With Bullish Institutional And Insider Buying Activities 12.04.12 | 04:12 pm
- Insiders Trading GHDX TZOO INFN KKD 11.26.12 | 09:11 am
- 5 Stocks Insiders Are Snapping Up 11.21.12 | 12:11 pm
- Insiders Trading GHDX ASCMA GNC SNTA 11.15.12 | 09:11 am
Press Releases for GHDX
- Genomic Health Announces Ten Studies Covering Breast, Colon And Prostate Cancers Accepted For Presentation At The American Society Of Clinical Oncology (ASCO) Annual Meeting - PR Newswire 05.21.13 | 08:05 am
- Genomic Health Announces Medicare Expanded Coverage Policy For Oncotype DX® Breast Cancer Test To Include Ductal Carcinoma In Situ (DCIS) Diagnosis - PR Newswire 05.10.13 | 04:05 pm
- Genomic Health Announces Availability Of Oncotype DX® Prostate Cancer Test With Potential To Triple The Number Of Patients Who Can Confidently Choose Active Surveillance And Avoid Side Effects Of Invasive Treatments - PR Newswire 05.08.13 | 08:05 am
- Genomic Health Announces Availability Of Oncotype DX® Prostate Cancer Test With Potential To Triple The Number Of Patients Who Can Confidently Choose Active Surveillance And Avoid Side Effects Of Invasive Treatments - PR Newswire 05.08.13 | 12:05 am
- Genomic Health To Present At Bank Of America Merrill Lynch Health Care Conference - PR Newswire 05.07.13 | 04:05 pm
- Genomic Health And ECOG-ACRIN Cancer Research Group Announce Publication Of Positive DCIS Validation Study In The Journal Of The National Cancer Institute - PR Newswire 05.02.13 | 04:05 pm
- Genomic Health Announces Investor Webcast And Conference Call To Review Positive Clinical Validation And Development Of The Oncotype DX® Prostate Cancer Test On Wednesday, May 8, 2013 - PR Newswire 05.01.13 | 04:05 pm
- Genomic Health To Announce First Quarter 2013 Financial Results And Host Conference Call On Thursday, May 2, 2013 - PR Newswire 04.25.13 | 08:04 am
- Genomic Health Announces Publication Of Second Positive Validation Of Oncotype DX Colon Cancer Test Confirming Its Value Beyond Conventional Markers - PR Newswire 04.17.13 | 08:04 am
- Genomic Health To Address One Of The Most Significant Needs In Men's Health With The Oncotype DX® Prostate Cancer Test - PR Newswire 04.03.13 | 08:04 am
Partner Headlines for GHDX
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying - Benzinga 05.18.13 | 03:05 pm
- Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test - Benzinga 05.10.13 | 04:05 pm
- Genomic Health Earnings: Here’s Why the Stock is Down Now - Wall St. Cheat Sheet 05.02.13 | 08:05 am
- Genomic Health, Inc. Enters Oversold Territory - Tale of the Tape - NASDAQ 09.12.12 | 03:09 pm
- Cepheid Remains Neutral - Analyst Blog - NASDAQ 08.22.12 | 06:08 pm
- Agilent Wins Patent in US - Analyst Blog - NASDAQ 08.21.12 | 07:08 pm
- Genomic Health Back to Neutral - Analyst Blog - NASDAQ 08.20.12 | 11:08 pm
- Genomic Health Beats on EPS - Analyst Blog - Zacks 08.09.12 | 10:08 am
- CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares - GuruFocus 07.13.12 | 02:07 pm
- Medical Sector Shows Muscle With SXC Health, Cerner - Investor's Business Daily 06.21.12 | 06:06 pm
